Nu Skin Trading Near 52-Week Low: Should You Buy or Sell NUS Stock?

Core Viewpoint - Nu Skin Enterprises, Inc. has experienced a significant decline in stock price, dropping as much as 38.7% over the past three months, underperforming compared to the industry and broader market indices [1][3] Group 1: Financial Performance - In Q2 2024, Nu Skin reported a 12.2% year-over-year decline in revenues, totaling $439.1 million, with a constant-currency revenue drop of 8% [3][4] - The company's customer base decreased by 14% to 893,514, and paid affiliates fell by 17% to 155,486 [3] - For 2024, Nu Skin anticipates revenues between$ 1.73 billion and $1.81 billion, indicating a decline of 12-8% from the previous year [5] Group 2: Market Challenges - Nu Skin is facing macroeconomic difficulties and a slow-moving direct-selling market, which have adversely affected its performance, particularly in the premium product segment [2][4] - Adverse currency fluctuations have negatively impacted revenues, with an estimated reduction of 3-4% expected for Q3 and full-year 2024 [4] Group 3: Analyst Sentiment - The Zacks Consensus Estimate for EPS has been revised downward by 29.1% and 26.6% for the current and next fiscal year, reflecting negative sentiment among analysts [6] - Nu Skin's stock is currently rated as a Zacks Rank 5 (Strong Sell), indicating a cautious outlook from investors [7]